A detailed history of Squarepoint Ops LLC transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 17,390 shares of LUCD stock, worth $18,781. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,390
Previous 112,235 84.51%
Holding current value
$18,781
Previous $129,000 86.82%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$0.97 - $1.48 $91,999 - $140,370
-94,845 Reduced 84.51%
17,390 $17,000
Q2 2025

Aug 27, 2025

BUY
$1.09 - $1.65 $89,067 - $134,826
81,713 Added 267.72%
112,235 $129,000
Q2 2025

Aug 14, 2025

BUY
$1.09 - $1.65 $89,067 - $134,826
81,713 Added 267.72%
112,235 $129,000
Q1 2025

Aug 27, 2025

SELL
$0.79 - $1.59 $64,553 - $129,923
-81,713 Reduced 72.81%
30,522 $45,000
Q1 2025

May 15, 2025

BUY
$0.79 - $1.59 $24,112 - $48,529
30,522 New
30,522 $45,000

Others Institutions Holding LUCD

About Lucid Diagnostics Inc.


  • Ticker LUCD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 38,568,500
  • Market Cap $41.7M
  • Description
  • Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...
More about LUCD
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.